He has appeared earlier for the sellers in the Delhi High Court.Former Ranbaxy promoters Malvinder Singh and Shivinder Singh are accused of concealing information regarding wrongdoing at Ranbaxy when they sold a majority stake in it to the Japanese firm in 2008. The sellers are seeking to have the award either set aside or a reduction in the quantum, in appeal. Daiichi, on the other hand, has applied to the court to have the award enforced.Salve filed an application in the top court seeking exemption from a Singapore law which bars foreign lawyers from appearing in local courts unless the court felt a "need" for his assistance considering his special qualifications or experience. He also mentioned his ample experience in this field to argue for an exception to be made in this case.But the Singapore Supreme Court in a decision on February 17, 2017, refused to allow him to appear citing several reasons for this.Among other things, the court said that no questions of Indian law were involved at this stage. The court imposed a $8,000 costs before dismissing the application, but the costs would be paid by the true party who stood to benefit from the application, not Salve.

Source: Economic Times February 21, 2017 18:56 UTC